EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.31 | 5'-AMP | - |
Rattus norvegicus | |
2.7.11.31 | 5-amino-4-imidazolecarboxamide ribonucleoside | - |
Rattus norvegicus | |
2.7.11.31 | adiponectin | - |
Rattus norvegicus | |
2.7.11.31 | leptin | - |
Rattus norvegicus | |
2.7.11.31 | metformin | antidiabetic drug | Rattus norvegicus | |
2.7.11.31 | additional information | AMPK can also be activated by hyperosmotic stress | Rattus norvegicus | |
2.7.11.31 | rosiglitazone | antidiabetic drug | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.11.31 | transfection of CCL13 cells | Rattus norvegicus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.11.31 | S485A | site-directed mutagenesis, non-phosphorylatable mutant | Rattus norvegicus |
2.7.11.31 | S485D | site-directed mutagenesis | Rattus norvegicus |
2.7.11.31 | T172E | site-directed mutagenesis | Rattus norvegicus |
2.7.11.31 | T258A | site-directed mutagenesis, non-phosphorylatable mutant | Rattus norvegicus |
2.7.11.31 | T258D | site-directed mutagenesis | Rattus norvegicus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.7.11.31 | 40000 | - |
1 * 63000 + 1 * 40000 + ?, alpha and beta subunit, SDS-PAGE | Rattus norvegicus |
2.7.11.31 | 63000 | - |
1 * 63000 + 1 * 40000 + ?, alpha and beta subunit, SDS-PAGE | Rattus norvegicus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.11.31 | ATP + [hydroxymethylglutaryl-CoA reductase (NADPH)] | Rattus norvegicus | activated AMPK acts to down-regulate ATP-consuming pathways such as fatty acid synthesis by phosphorylating and inactivating acetyl-CoA carboxylase and protein synthesis by promoting the phosphorylation of eukaryotic elongation factor-2, in heart AMPK activation stimulates glycolysis by increasing glucose uptake | ADP + [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.11.31 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.11.31 | wild-type and mutant enzymes, expressed in bacteria | Rattus norvegicus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.11.31 | liver | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.11.31 | ATP + histone 2A | - |
Rattus norvegicus | ? | - |
? | |
2.7.11.31 | ATP + [hydroxymethylglutaryl-CoA reductase (NADPH)] | activated AMPK acts to down-regulate ATP-consuming pathways such as fatty acid synthesis by phosphorylating and inactivating acetyl-CoA carboxylase and protein synthesis by promoting the phosphorylation of eukaryotic elongation factor-2, in heart AMPK activation stimulates glycolysis by increasing glucose uptake | Rattus norvegicus | ADP + [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.7.11.31 | heterotrimer | 1 * 63000 + 1 * 40000 + ?, alpha and beta subunit, SDS-PAGE | Rattus norvegicus |
2.7.11.31 | More | heterotrimeric serine/threonine kinase consists of a catalytic alpha-subunit and 2 regulatory subunits beta and gamma, each subunit exists as multiple isoforms, alpha1, alpha2, beta1, beta2, gamma1, gamma2 and gamma3, giving 12 different possible combinantions of holoenzyme with different tissue distribution and subcellular localization | Rattus norvegicus |